CN-STANDARD
Notice: 421284-2026
Spain – Pharmaceutical products – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib
| Contracting Authority | ICS - Gerència de compres |
| Country | Spain (ESP) |
| CPV Code | 33600000 |
| Publication Date | 19 June 2026 |
| Deadline | Not specified |
| Value | Not specified |
| Currency | EUR |
| Notice Type | cn-standard |
📄 Full notice available on TED Europa (EU Official Journal of the European Union)
View Full Notice on TED →